Background Neoadjuvant radiotherapy (RT) has been shown to improve local control;
however, whether it can improve overall survival (OS) in locally advanced rectal cancer …

BACKGROUND For locally advanced rectal cancer (LARC), standard therapy [consisting of
neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] …

Neoadjuvant chemoradiotherapy (nCRT) plus total mesorectal excision (TME) has been the
standard regimen for treatment of patients with locally advanced rectal cancer (LARC) …

Background: During the last decade, one of the most important treatment options for locally
advanced, potencially resectable rectal tumours was neoadjuvant chemoradiotherapy (CRT) …

Background/Aim: Controversy exists regarding treatment of high rectal cancer. The role of
neoadjuvant radio-chemotherapy was investigated. Patients and Methods: Fifty-four patients …

BACKGROUND Distant relapse is the leading cause of cancer-related death in locally
advanced rectal cancer. Neoadjuvant chemoradiation (NACRT) followed by surgery …

Purpose The status of tumor regression in rectal cancer after neoadjuvant concurrent
chemoradiotherapy (CCRT) has significant effect on tumor recurrence and patient survival …

Background/Aim: The value of neoadjuvant radiochemotherapy for high rectal cancers is
controversial. This study compared surgery plus neoadjuvant radiochemotherapy to surgery …

Purpose Currently, neoadjuvant chemoradiation (CRT) followed by total mesorectal
resection is considered the standard of care for treating locally advanced rectal cancer. This …

Objective. To analyze the efficacy of combining sintilimab with neoadjuvant chemotherapy in
treating middle and advanced rectal cancer based on big data. Methods. According to the …